Therapy for cervical cancer detected by mass screening

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer screening programs are crucial for early detection and improved patient outcomes.
• Understanding the effectiveness of mass versus private screening methods is vital for public health strategies.

Purpose of the Study:

• To evaluate the detection rates and survival outcomes of cervical cancer identified through mass screening in Miyagi Prefecture.
• To compare the characteristics and prognoses of cervical cancers detected by mass screening versus private screening.

Main Methods:

• Retrospective analysis of 972 cervical cancer cases detected via mass screening between 1962 and 1981.
• Comparison of detection rates and cancer staging between mass and private screening methods.
• Calculation of 5-year survival rates based on cancer stage for mass-screened patients.

Main Results:

• Mass screening yielded a 0.11% detection rate (972 cases), with 56.7% being carcinoma in situ.
• Private screening had a higher detection rate (0.39%, 889 cases), with 68.7% being invasive carcinoma.
• For mass-screened invasive cancers, 88.7% had a 5-year survival rate, with no deaths from carcinoma in situ recurrence.

Conclusions:

• Mass screening effectively detects cervical cancer, including early-stage carcinoma in situ, leading to high survival rates.
• Early detection through mass screening significantly reduces mortality from cervical cancer.
• The study highlights the public health benefits of organized cervical cancer screening programs.